YOUR BUSINESS AUTHORITY
Springfield, MO
Eli Lilly has inked a $3.2 billion acquisition deal.
The company is buying Morphic Holding in a bid to expand its portfolio of inflammatory bowel disease drugs.
Morphic Holding's stock surged on the announcement.
Read more from Reuters.
Project work in Springfield corridor will continue into 2031.